(Q39749438)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Richard Mailman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

Mark von Zastrow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Gabriel A Vargas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

22 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

67-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554739%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301071

18 January 2020

exact match

0 references

cites work

Partial agonism and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Phospholipase A(2) isoforms: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Half a century of antipsychotics and still a central role for dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Agonist trafficking of G(i/o)-mediated alpha(2A)-adrenoceptor responses in HEL 92.1.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Pharmacological characterization of putative β1-β2-adrenergic receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Beta-adrenergic receptors: Regulatory role of agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

α- and β-adrenergic stimulation of arachidonic acid metabolism in cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Dopamine partial agonists: a new class of antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

The origins of diversity and specificity in g protein-coupled receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Functional selectivity, ligand-directed trafficking, conformation-specific agonism: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Partial dopamine agonists in the treatment of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Schizophrenic Symptoms Improve with Apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Identification of a novel endocytic recycling signal in the D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

EVIDENCE FOR A ROLE OF DOPAMINE IN EXTRAPYRAMIDAL FUNCTIONS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

D2 dopamine receptors stimulate mitogenesis through pertussis toxin-sensitive G proteins and Ras-involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

Dopamine receptors: from structure to function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

Pharmacologic properties of (-)-3PPP (preclamol) in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301071

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301071

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/phc7xpwfofclxirreiymqiggcm

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_phc7xpwfofclxirreiymqiggcm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/phc7xpwfofclxirreiymqiggcm

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/phc7xpwfofclxirreiymqiggcm

1 reference

30 July 2022